Location of Repository

Studies on the Genome Structure of Neurovirulent and Attenuated Polioviruses

By Alan James Cann


The RNA genomes of neurovirulent and attenuated type 3 polioviruses have been cloned in E. cola using an efficient RNA.cDNA hybrid technique.\ud The complete nucleotide sequence of the vaccine-associated neurovirulent revertant P3/119 and, in collaboration with others, the attenuated vaccine strain P3/Leon 12 a1b, have been determined. These have been compared with that of the neurovirulent parent strain P3/Leon/3 7. Ten nucleotide sequence differences were observed between the parent P3/Leon/37 and the vaccine P3/Leon 12 a1b, three of which resulted in amino acid substitutions. Between the vaccine and the revertant P3/119, seven nucleotide sequence differences were observed. Three of these resulted in amino acid substitutions. The possible significance of individual nucleotide sequence differences to the attenuation of and reversion to neurovirulence in poliovirus type 3 is discussed.\ud The nucleotide sequence of P3/Leon 12 a1b was the first to be determined for a type 3 poliovirus. Comparison of this sequence with published type 1 sequences has demonstrated the extent of the molecular homology between them

Publisher: University of Leicester
Year: 1984
OAI identifier: oai:lra.le.ac.uk:2381/9058

Suggested articles



  1. (1982). 33rd report of the WHO expert committee on biological standardization. WHO technical reports series 687,
  2. (1981). 5'-terminal sequences of eukaryotic mRNA can be cloned with high efficiency.
  3. (1978). 51-terminal nucleotide sequences in the genome RNA of picornaviruses.
  4. (1977). 51-terminal nucleotide sequences of poliovirus polyribosomal RNA & viral RNA are identical.
  5. (1981). A comparison of polioviruses by cDNA: RNA hybridization.
  6. (1976). A general method for the cloning of eukaryotic structural gene sequences.
  7. (1968). A genetic map of poliovirus temperature-sensitive mutants.
  8. (1971). A history of poliomyelitis.
  9. (1982). A membrane-associated precursor of poliovirus VPg identified by immunoprecipitation with antibodies directed against a synthetic heptapeptide.
  10. (1972). A model for foot-and-mouth disease virus.
  11. (1980). A new computer method for the storage & manipulation of DNA gel reading data. Nucleic Acids Res.
  12. (1982). A new genetics of poliovirus.
  13. (1977). A new method for sequencing DNA.
  14. (1982). A new pair of M13 vectors for selecting either DNA strand of double-stranded restriction fragments.
  15. (1960). A physical property as a virus marker: Difference in avidity of cellulose resin for virulent (Mahoney) & attenuated (LSc tab) strains of type 1 poliovirus.
  16. (1981). A plasmid DNA primase active in discontinuous bacterial DNA replication.
  17. (1983). A poliovirus type I neutralization epitope is located within amino acid residues 93-104 of viral capsid polypeptide VP1.
  18. (1979). A rapid alkaline extraction procedure for screening recombinant plasmid DNA. Nucleic Acids Res.
  19. (1981). A rapid boiling method for the preparation of bacterial plasmids.
  20. (1975). A rapid method for determining sequences in DNA by primed synthesis with DNA polymerase.
  21. (1976). A simple method for DNA restriction site mapping-
  22. (1956). A study of the basic aspects of neutralization of two animal viruses, Western Equine Encephalitis Virus & Poliomyelitis Virus.
  23. (1974). A system for mapping DNA sequences in the chromosomes of D.
  24. (1981). A system for shotgun DNA sequencing. Nucleic Acids is.
  25. (1982). A tandem repeat gene in a picornavirus. Nucleic Acids Res.
  26. (1935). Active immunization against poliovirus.
  27. (1950). Acute poliomyelitis: Relation of physical activity at the time of onset to the course of the disease.
  28. (1979). Addition of homopolymers to the 3' ends of duplex DNA with terminal transferase.
  29. (1979). Addition of oligonucleotides to the 5'-terminus of DNA by T4 RNA ligase. Nucleic Acids Res.
  30. (1978). Advantages & disadvantages of killed & live poliomyelitis vaccines.
  31. (1970). Ae
  32. (1978). Aggregation of entrovirus small plaque variants polioviruses under low ionic strength conditions.
  33. (1976). Amplification & characterization of a beta-globin gene synthesized in vitro.
  34. (1978). An enzymatic activity in uninfected cells that cleaves the linkage between poliovirion RNA & the 5'-terminal protein.
  35. (1977). An extended genetic recombination map for foot-and-mouth disease virus.
  36. (1981). An improved procedure for utilizing terminal transferase to add homopolymers to the 3' termini of DNA.
  37. (1977). Analysis of restriction fragments of T7 DNA & determination of molecular weight by electrophoresis in neutral & alkaline gels.
  38. (1982). Anti-VPg antibody inhibition of the poliovirus replicase complex & production of covalent complexes of VPg-related proteins & RNA.
  39. (1982). Antibodies against a pre-selected peptide recognise & neutrallse foot-and-mouth disease virus.
  40. (1982). Antibodies against a synthetic peptide of poliovirus replicase protein: Reaction with native, virus-encoded proteins & inhibition of virus-specific polymerase activities.
  41. (1982). Antibody to a host protein prevents initiation by the poliovirus replicase.
  42. (1983). Antibody to a host-factor precipitates poliovirus RNA polymerase from poliovirus infected cells.
  43. (1983). Antibody to a synthetic nonapeptide corresponding to the amino terminus of poliovirus genome-linked protein VPg reacts with native VPg & inhibits in vitro replication of poliovirus RNA.
  44. (1976). Anticomplementary small cDNA produced during synthesis of polio cDNA.
  45. (1981). Antigenic structure of poLiovirus.
  46. (1975). Attempts to extend the genetic map of poliovirus temperature-sensitive mutants.
  47. (1968). Attempts to map the poliovirus genome by analysis of selected recombinants.
  48. (1982). Automation of the computer handling of gel reading data produced by the shotgun method of DNA sequencing.
  49. (1976). Bacterial cloning of plasmids carrying copies of rabbit globin messenger RNAo
  50. (1977). Biochemical analysis of virulent & avirulent strains of foot-and-mouth disease virus.
  51. (1982). Biochemical evidence of recombination within the unsegmented RNA genome of apthovirus.
  52. (1981). Biochemical identification of viruses causing the 1981 outbreaks of foot-and-mouth disease in the UK.
  53. (1972). Biochemical method for inserting new genetic information into
  54. (1975). Biochemical method for mapping mutational alterations
  55. (1983). Bivalent attachment of antibody onto poliovirus leads to conformational alteration & neutralization.
  56. (1980). Brazilian paralysis - the real disease.
  57. (1983). Buffer gradient gels as an aid to rapid DNA sequence determination.
  58. (1970). Calcium dependent bacteriophage DNA transfection.
  59. (1963). Calcium phosphate adsorption patterns of virulent & attenuated strains of poliovirus.
  60. (1980). Changes in .3 of the 4 coat proteins of oral poliovaccine strain derived from type 1 poliovirus.
  61. (1983). Characterization of an antigenic determinant of the glycoprotein that correlates with the pathogenicity of rabies virus.
  62. (1982). Characterization of strains of type 3 poliovirus by oligonucleotide mapping.
  63. (1983). Chemical basis of antigenic variation in foot-and-mouth disease virus.
  64. (1982). Classification & nomenclature of viruses.
  65. (1981). Cloned poliovirus complementary DNA is infectious in mammalian cells.
  66. (1981). Cloned viral protein vaccines for foot-and-mouth disease: Responses in cattle & swine.
  67. (1980). Cloning in single- stranded bacteriophage as an aid to rapid DNA sequencing.
  68. (1981). Cloning of cDNA of major antigen of foot-and-mouth disease virus & expression in E. coll.
  69. (1981). Cloning of X-2u globulin cDNA using a high efficiency technique for the cloning of trace messenger RNA's.
  70. (1975). Colony hybridisation: A method for the isolation of cloned DNA's that contain a specific gene.
  71. (1980). Comparative biochemical studies of type 3 polioviruses.
  72. (1979). Comparative monkey neurovirulence of Sabin type III poliovirus vaccines.
  73. (1981). Comparative sequence analysis of the 51-terminal non-coding regions of poliovirus vaccine strains
  74. (1982). Comparison of the amino acid sequence of the major immunogen from 3 serotypes of foot-and-mouth disease virus.
  75. (1979). Comparison of the antibodies elicited by the individual structural polypeptides of foot-and-mouth disease virus & poliovirus.
  76. (1983). Comparison of the major antigenic determinants of different serotypes of foot-andmouth disease virus.
  77. (1982). Complete sequence of the attenuated poliovirus Sabin 1 strain.
  78. (1977). Construction & characterization of new cloning vehicles II. A multipurpose cloning system.
  79. (1974). Covalent attachment of polyribonucleotides to polydeoxyribonucleotides catalysed by deoxyribonucleic acid ligase.
  80. (1977). Covalent linkage of a protein to a defined nucleotide sequence at the 5'-terminus of virion & replicative-intermediate RNA's of poliovirus.
  81. (1983). Coxsackie B virus infections in cardiac disease.
  82. (1983). Critical role of an eight amino acid sequence in the neutralization of poliovirus.
  83. (1955). Crystallization of purified MEF-1 poliomyelitis virus particles.
  84. (1936). Cultivation of poliovirus in vitro in human embryonic nervous tissue.
  85. (1949). Cultivation of the Lansing strain of poliovirus in cultures of various human embryonic tissues.
  86. (1969). Death & transfiguration of a problem.
  87. (1976). Defect in translation of poliovirus RNA at the restrictive temperature.
  88. (1983). Detection by monoclonal antibodies of an antigenic determinant critical for poliovirus neutralization present on VP1 & on heatinactivated virions.
  89. (1971). Determination of the gene sequence of poliovirus with pactamycin.
  90. (1979). Determination of the length distribution of poly(A) at the 3'-terminus of the virion RNA's of EMC virus, poliovirus, rhinovirus, RAV-61 & of mouse globin mRNA.
  91. (1977). DNA sequencing with chain terminating Inhibitors.
  92. (1973). Early events in cell-animal virus interactions.
  93. (1962). Early stages of the enterovirus infection. Cold Spring Harbor Symp.
  94. (1981). Effect of growth rate & nutrient limitation on the transformability of E. coli with plasmid DNA.
  95. (1981). Effect of mutation on the virulence in mice of a strain of foot-and-mouth disease virus.
  96. (1976). Efficient transcriPtion of M; A into DNA by avian sarcoitLa virus polymerase.
  97. (1979). Efficient transfer of large DNA fragments from agarose gels to diazobenzoylmethyl paper & rapid hybridization by using dextran sulphate.
  98. (1959). Electron microscope studies of the development & structure of poliomyelitis virus.
  99. (1980). Elimination of the secondary structure effect in gel sequencing of nucleic acids.
  100. (1981). EMC virus RNA can be translated under conditions of poliovirus induced shut-off.
  101. (1978). Empirical predictions of protein conformation.
  102. (1955). Enteric cytopathic hman orphan viruses.
  103. (1978). Enteroviruses in human disease.
  104. (1976). Enzymatic in vitro synthesis of globin genes.
  105. (1980). Enzymatic synthesis of DNA by AMV reverse transcriptase in vitro: Optimum conditions for transcription of large RNA templates.
  106. (1980). Eradication of poliomyelitis in the United States.
  107. (1980). Evidence for a selfcleaving precursor of virus coded protease,
  108. (1982). Evidence for intramolecular selfcleavage of picornaviral replicase precursors.
  109. (1963). Evidence for multiple components in the structural protein of type 1 poliovirus.
  110. (1969). Evidence of the saftey & efficacy of live poliomyelitis vaccines currently in use, with special reference to type III poliovirus.
  111. (1977). Evolution of poliovirus since the introduction of attenuated vaccine.
  112. (1959). Factors influencing the evolution of viral diseases at the cellular level & in the organism.
  113. (1969). Filamentous bacterial viruses.
  114. (1977). Filamentous coliphage M13 as a cloning vehicle: Insertion of a HindII fragment of the lac regulatory region in M13 replicative form in vitro.
  115. (1980). Fragility of the rhinovirus type 14 genome to incubation at 600 C.
  116. (1971). Fragments generated by pH dissociation of ME virus & their relation to the structure of the virion.
  117. (1978). Functional expression of cloned yeast DNA in E. coli: Specific complementation of arginosuccinate lyase (argH) mutations.
  118. (1977). Gene expression 3. Wiley Interscience,
  119. (1979). General organisation & structure of the picornavirus genomeo p.
  120. (1962). Genetic recombination with Newcastle disease virus, polioviruses & influenza.
  121. (1963). Genetic recombination with poliovirus type 1. Studies of crosses between a normal horse serum resistant mutant & several guanidine resistant mutants of the same strain. Virology ZO,
  122. (1962). Helix formation by guanylic acid.
  123. (1983). Hepadnaviruses: Hepatitis B& related viruses. Current Tb pics in Microbiol.
  124. (1980). Heterogeneity of the genome-linked protein of foot-and-mouth disease virus.
  125. (1982). High efficiency cloning of full-length cDNA.
  126. (1949). Histopathological basis of clinical findings in poliomyelitis.
  127. (1973). History of Sabin attenuated poliovirus oral live vaccine strains.
  128. (1978). How do eukaryotic ribosomes select initiation regions in messenger RNA?
  129. (1974). Human chromosome 19 carries a poliovirus receptor gene.
  130. (1983). Identification of a poliovirus neutralizing epitope through use of neutralizing antiserum raised against a purified viral structural protein.
  131. (1982). Identification of the initiation site of poliovirus polyprotein synthesis.
  132. (1981). Identification. or point mutations in the genome of poliovirus
  133. (1975). Immune & antibody responses to an isolated capsid protein of foot-and-mouth disease virus.
  134. (1982). In vitro copying of viral positive strand RNA by poliovirus replicase. Characterization of the reaction & its products.
  135. (1979). In vitro translation of picornavirus RNA.
  136. (1980). Induction of neutralizing antibodies by the mxsackie B3 virion protein VP2.
  137. (1983). Infectious vaccinia virus recombinants that express hepatitis B virus surface antigen.
  138. (1978). Inhibition of intractable nucleases with ribonucleoside-vanadyl complexes: Isolation of messenger ribonucleic acid from resting lymphocytes.
  139. (1976). Integration of synthetic globin genes into an E. coli plasmid. NUClOiC Acids Res.
  140. (1983). Intertypic recombination in poliovirus: Genetic & biochemical studies.
  141. (1979). Intertypic serodifferentiation of poliomyelitis virus strains by strain-specific sera.
  142. (1977). Is poliomyelitis a serious problem in developing countries?
  143. (1980). Isolation of developmentally regulated genes from D.
  144. (1977). Labelling DNA to high specific activity by in vitro nick-translation with DNA polymerase I.
  145. (1980). Linkage of adult alpha & beta-globin genes in X. laevis & gene duplication by tetraploidization.
  146. (1982). Location & characterization of the antigenic portion of the foot-and-mouth disease virus immunizing protein.
  147. (1983). Location & primary structure of a major antigenic site for poliovirus neutralization.
  148. (1983). Location of an immunizing determinant within polypeptide VP1 of type 0 apthovirus.
  149. (1980). Location of the initiation site for protein synthesis on foot-andmouth disease virus RNA by in vitro translation of defined fragments of RNA.
  150. (1968). M4rphogenesis of poliovirus I. Association of the viral RNA with the coat protein.
  151. (1983). Membrane fractions active in poliovirus RNA replication contain VPg precursor polypeptides.
  152. (1982). Meningitis, encephalitis & poliomyelitis.
  153. (1978). Methylation of single-stranded DNA in vitro introduces new restriction endonuclease cleavage sites.
  154. (1979). Methylmercury enhancement of translation of ovalbumin & conalbumin mRNA's.
  155. (1983). Molecular cloning of cDNA from foot-and-mouth disease virus CI-Santa Pau (C-58). Sequence of protein VP1 coding segment.
  156. (1983). Molecular cloning of cDNA: Preparation of plasmid vector with low transformation background.
  157. (1981). molecular cloning of poliovirus cDNA & determination of the complete nucleotide sequence of the viral genome.
  158. (1981). Molecular cloning of the foot-andmouth disease virus genome & nucleotide sequences in the structural protein genes.
  159. (1981). molecular cloning of the genome of poliovirus type 1.
  160. (1981). Molecular variation of type 1 vaccine-related & wild polioviruses during replication in humans.
  161. (1980). Monkey neurovirulence of live attenuated (Sabin) type 1& type 2 poliovirus vaccines.
  162. (1983). Monoclonal antibodies that inhibit attachment of group
  163. (1978). More precise location of the polycytidylic acid tract in foot-and-mouth disease virus RNA.
  164. (1981). Multiple genetic changes in the oral poliovaccines upon replication in humans.
  165. (1957). Mutants of poliomyelitis virus with reduced efficiecy of plating in acid moditin a reduced neuropathogenicity.
  166. (1979). Nacleotide sequence analysis of leader segments in a cloned copy of adenovirus 2 fiber
  167. (1967). Nature of the inactivating action of trypoin on foot-and-mouth disease virus.
  168. (1983). Neutralization of poliovirus by monoclonal antibody: Kinetics & stoichiometry.
  169. (1972). Non-chromosomal antibiotic resistance in bacteria: Genetic transformation of E. coli by R-factor DNA.
  170. (1983). Nucleic acid sequence of the region of the genome encoding capsid. protein VP1 of neurovirulent & attenuated type 3 polioviruses.
  171. (1981). Nucleotide & corresponding amino acid sequence of the gene for the major antigen of foot-and-mouth disease virus.
  172. (1983). Nucleotide sequence of the haemagglutinin gene of influenza virus A/England/321/77.
  173. (1982). Oligonucleotide mapping: Evaluation of its sensitivity by computer simulation.
  174. (1964). On the mechanism of genetic recombination between DNA molecules.
  175. (1976). On the structure & morphogenesis of picornaviruses.
  176. (1971). On the structure of rhinovirus 1A.
  177. (1965). Oral poliovirus vaccine.
  178. (1981). Paralytic poliomyelitis: old dogmas & new perspectives.
  179. (1978). Parameters for differentiating vaccine-derived & wild poliovirus strains.
  180. (1956). Pathogenesis of poliomyelitis. Re-appraisal in the light of new data.
  181. (1978). pBR 322 restriction map derived from the DNA sequenceo Nucleic Acids Res.
  182. (1964). Picornavirus symmetry.
  183. (1979). Plasmid transformation of E. coli.
  184. (1973). Poliomyelitis in hypogammaglobulinaemics.
  185. (1954). Poliomyelitis infections in households. Frequency of viremia & specific antibody response.
  186. (1982). Poliomyelitis surveillance
  187. (1982). Poliovirus induced inhibition of host cell protein synthesis.
  188. (1983). Poliovirus P-14A synthesis in vitro: Structural elements & antibody inhibition.
  189. (1979). Poliovirus replicase: A soluble enzyme able to initiate copying of poliovirus RNA.
  190. (1978). poliovirus single-stranded RNA & double-stranded RNA: Differential infectivity in enucleate cells.
  191. (1983). Poliovirus type 3: Molecular cloning of the genome & nucleotide sequence of the region encoding the protease & polymerase proteins. Nucleic Acids Res.
  192. (1973). Polioviruses, Ooxsackieviruses & Echoviruses: comparison of the genomes by RNA hybridization.
  193. (1974). Poly(C) in animal virus RNA's.
  194. (1974). Poly(U) in poliovirus minus RNA is 51-terminal.
  195. (1972). Polyadenylic acid at the 31-terminus of poliovirus RNA.
  196. (1968). Polypeptide cleavages in the formation of poliovirus proteins.
  197. (1982). Possible location of the gene of human cell sensitivity to Oxsackie B virus in the short arm of chromosome 21.
  198. (1981). Possible role of flanking oligonucleotides in recognition of the AUG initiator codon by eukaryotic ribosomes.
  199. (1983). Pour independent antigenic determinants on the capsid polypeptides of apthovirus.
  200. (1981). Prediction of protein antigenic determinants from amino acid sequences.
  201. (1974). Presence of a large poly(rC) tract within the RNA of EMCV.
  202. (1981). Primary structure, gene organisation a polypeptide expression of poliovirus RNA.
  203. (1983). Priming for & induction of anti-poliovirus neutralizing antibodies by synthetic peptides.
  204. (1979). Prolonged incubation in calcium chloride improves the competence of E. cola cells.
  205. (1982). Protection against foot-and-mouth disease by immunization with a chemically synthesized peptide predicted from the viral nucleotide sequence.
  206. (1977). Protein covalently linked to foot-and-mouth disease virus RNA.
  207. (1983). Protein synthesis eukaryotic initiation factors 4A & 4B are not altered by poliovirus infection of HeLa cells.
  208. (1971). Proteolytic cleavage of native DNA polymerase into two different catalytic fragments.
  209. (1982). Proteolytic processing of poliovirus peptides: Antibodies to polypeptide P3-7c inhibit cleavage at glutamine-glycine pairs.
  210. (1980). Purification & properties of a HeLa cell enzyme able to remove the terminal protein from poliovirus RNA.
  211. (1983). Purification of a host-factor required for in vivo transcription of poliovirus RNA.
  212. (1983). Random subcloning of sonicated DNA: Application to shotgun DNA sequence analysis.
  213. (1982). Rapid evolution of RNA genomes.
  214. (1981). Re-assessment of the place of inactivated poliomyelitis vaccine in national immunization programs.
  215. (1979). Recombinant DNA techniques.
  216. (1981). Recovery of DNA fragments inserted by the tailing method: Regeneration of PstI restriction sites.
  217. (1982). Relation between acute persisting spinal paralysis & poliomyelitis vaccine, results of a ten year study.
  218. (1981). Removal of the genome-linked protein of foot-and-mouth disease virus by rabbit reticulocyte lysate.
  219. (1961). Reproductive capacity of polioviruses of diverse origins at various temperatures.
  220. (1974). Requirement of 31-terminal polyadenylic acid for the infectivity of polivirus.
  221. (1982). Restriction map of double-stranded DNA copy synthesised from poliovirus Sabin type 1 RNA.
  222. (1980). Restriction-modification enzymes & their recognition sequences.
  223. (1979). Reverse transcriptase from Avian Myeloblastosis Virus.
  224. (1982). Routine immunisation in adults.
  225. (1977). S' structures of poliovirus RNA MRNA differ only in VPg.
  226. (1983). Sequence analysis of zein cDNA's obtained by an efficient cloning method.
  227. (1980). Sequence of 1060 nucleotides from the 31 terminal end of polio RNA determined by a modified dideoxynucleotide method.
  228. (1980). Shut-off of HeLa protein synthesis by EMCV & poliovirus: A comparative study.
  229. (1978). Sodiua pyrophosphate inhibition of RNA-DNA hybrid degradation by reverse transcriptase.
  230. (1960). Some techniques for producing & studying attenuated strains of the virus of foot-and-mouth disease.
  231. (1982). Specific cross-linking of capsid protein to virus R14A by ultra--violet irradiation of poliovirus.
  232. (1981). Stable hairpin structure within the 5'-terminal 85 nucleotides of poliovirus RNA.
  233. (1971). Stepwise degradation of poliovirus by alkaline treatment.
  234. (1975). Structure & assembly of virulent & attenuated strains of poliovirus.
  235. (1979). Structure independent nucleotide sequence analysis.
  236. (1980). Structure of cloned cDNA of rat proinsulin messenger RNA.
  237. (1959). Structure of poliomyelitis virus.
  238. (1977). Structure of the mengo virion. Distribution of the capsid polypeptides with respect to the surface of the virus particle.
  239. (1979). Structure-function relationships in the picornaviruses.
  240. (1983). Studies on the in vitro uncoating of poliovirus IV: Characteristics of solubilized membranemodifying & stabilizing factors.
  241. (1966). Studies on the structure of poliovirus.
  242. (1965). Studies on the structure of viruses of the Columbia SK group II. The protein subunits of ME virus, EMC virus & Mengo virus.
  243. (1954). Studies on variants of poliomyelitis virus Experimental segregation & properties of avirulent mutants of 3 immunologic types.
  244. (1978). Synthesis of full-length cDNA's from partially purified oviduct mRNA's.
  245. (1976). Synthesis of possible complete copies of polio RNA.
  246. (1983). T-munochemical studies of polioviruses: Identification of immunoreactive virus capsid polypeptides.
  247. (1980). Temperature-sensitive mutants of footand-mouth disease virus with altered structural polypeptides I: Identification by electrofocusing.
  248. (1968). Temperature-sensitive mutants of influenza A virus: Isolation of mutants & preliminary observation on genetic recombination & complementation.
  249. (1980). Temperaturesensitive mutants of foot-and-mouth disease virus with altered structural polypeptides II: Comparison of recombinational & biochemical maps.
  250. (1976). Terminal labelling & addition of homopolymer tracts to duplex DNA fragments by terminal deoxynucleotidyl transferase. Nucleic Acids Res.
  251. (1976). The 51 end of poliovirus mRNA is not capped with m7GpppNp. proc.
  252. (1982). The advent of antiviral drugs & the search for drugs useful for hunan enteroviral diseases.
  253. (1964). The behavoir of attenuated strains of poliovirus in monkeys.
  254. (1977). The behavoir of Sabin attenuated poliovirus strains in the central nervous system of rhesus monkeys.
  255. (1949). The Coxsackie group of viruses.
  256. (1980). The cultivation of the poliomyelitis viruses in tissue culture.
  257. (1981). The epidemiology of poliomyelitis
  258. (1979). The epidemiology of poliomyelitis: Enigmas surrounding its appearance, epidemicity & disappearance.
  259. (1971). The expression of animal virus genomes.
  260. (1981). The fate of VPg during in vitro translation of poliovirus RNA.
  261. (1969). The genetic analysis of poliovirus.
  262. (1978). The immunological response of Nigerian infants to attenuated & inactivated poliovaccines.
  263. (1961). The influence of technique on the sensitivity of monkeys to intraspinally inoculated poliovirus.
  264. (1980). The influence of the host cell on the inhibition of virus protein synthesis in cells doubly infected with VSV &
  265. (1981). The isolation of cdysterone inducible genes by hybridisation subtraction hromatography. Nucleic Acids Res.
  266. (1977). The location of the polio genome protein in viral RNA & its implcations for RNA synthesis.
  267. (1979). The mechanism & cytoplasmic control of mammalian protein synthesis.
  268. (1983). The molecular basis of antigenic variation of foot-and-mouth disease virus.
  269. (1983). The nucleotide sequence of poliovirus type 3 Leon 12 a1b: Comparison with poliovirus type 1. Nucleic Acids Iles.
  270. (1976). The ovalbunin gene: In vitro enzymatic synthesis & characterization.
  271. (1979). The picornavirion: Structure & assembly. pol-23
  272. (1981). The preparation a screening of a cDNA clone bank.
  273. (1969). The replication of picornaviruses.
  274. (1976). The replication of rhinoviruses.
  275. (1982). The structure & replication of rhinoviruses.
  276. (1960). The vacuolating virus
  277. (1972). Theronosensitive block of the Sabin strain of poliovirus type 1.
  278. (1979). Topographical studies on poliovirus capsid proteins by chemical modification & cross-linking with bifunctional reagents.
  279. (1982). Towards the eradication of poliomyelitis.
  280. (1980). Transcomplementable copy number mutants of plasmid Col-El.
  281. (1970). Transcription of the vaccinia virus genome & the occurrence of polyriboadenylic acid sequences in the messenger RNA. Cold Spring Harbor Symp.
  282. (1978). Transfection of Enterobacteriaceae & its applications.
  283. (1977). Transformation in E. coli: Cryogenic preservation of competent cells.
  284. (1963). Unterscuchungen aber kleine E. cola bacteriophagen I. Die Isolierung und einige eigenschaften der kleinen bacteriophagen M12, M13 und M20.
  285. (1983). Use of temperature sensitive mutants to study the morphogenesis of poliovirus.
  286. (1982). Variation of influenza A, B&C viruses.
  287. (1977). Viral vaccines.
  288. (1954). Viremia in human poliomyelitis.
  289. (1957). Virulence of polioviruses in relation to variant characteristics distinguishable on cells in vitro.
  290. (1975). Virus developuent in enucleate cells: Echovirus, poliovirus, pseudorabies virus, reovirus,
  291. (1983). Virus infections in pregnancy & the puerperitum. p.
  292. (1977). Weekly Epidemiological Record 52,145.

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.